Aβ, tau and ApoE4 in Alzheimer's disease:: the axonal connect ion

被引:54
|
作者
Adalbert, Robert [1 ]
Gilley, Jonathan [1 ]
Coleman, Michael P. [1 ]
机构
[1] Babraham Inst, Cambridge CB22 3AT, England
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.molmed.2007.02.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in amyloid precursor protein (APP), tau and apolipoprotein E4 (ApoE4) lead to Alzheimer's disease (AD) or related pathologies. Pathogenesis and interactions between these pathways have been studied in mouse models. Here, we highlight the fact that axons are important sites of cellular pathology in each pathway and propose that pathway convergence at the molecular level might occur in axons. Recent developments suggest that axonal transport of APP influences beta-amyloid deposition and that tau regulates axonal transport. ApoE4 influences both axonal tau phosphorylation and amyloid-induced neurite pathology. Thus, a better understanding of axonal events in AD might help connect the pathogenic mechanisms of beta-amyloid, ApoE4 and tau, indicating the most important steps for therapeutic targeting.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 50 条
  • [1] Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease
    Almos, Peter Z.
    Horvath, Szatmar
    Czibula, Agnes
    Rasko, Istvan
    Domjan, Nora
    Juhasz, Anna
    Janka, Zoltan
    Kalman, Janos
    PSYCHIATRY RESEARCH, 2011, 186 (2-3) : 448 - 450
  • [2] APOE4 testing for Alzheimer's disease
    Karlawish, JHT
    Sachs, GA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) : 1153 - 1154
  • [3] ALZHEIMER DISEASE ApoE4 implicated in tau-mediated neurodegeneration
    Wood, Heather
    NATURE REVIEWS NEUROLOGY, 2017, 13 (12) : 706 - 706
  • [4] ApoE4: A RISK FACTOR FOR ALZHEIMER'S DISEASE
    Agarwala, A.
    Durakoglugil, M.
    Xian, D.
    Bowen, I
    Herz, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (02) : 469 - 469
  • [5] Epigenetic Downregulation of ApoE4 for Alzheimer's Disease
    Asmus, Natalie
    Moncalvo, Malik
    Dong, Wendy
    Ilich, Ekaterina
    Falek, Carmel
    Rittiner, Joseph
    Tringali, Domenic
    Yun, Young
    Gu, Jeffrey
    Wei, Angela
    Yang, Anna
    Angrist, Misha
    Chiba-Falek, Ornit
    Kantor, Boris
    MOLECULAR THERAPY, 2020, 28 (04) : 430 - 430
  • [6] APOE4, Alzheimer's and periodontal disease: A scoping review
    Arevalo-Caro, Catalina
    Retana, Marianela Arce
    Amaya, Sergio Losada
    Arboleda, Humberto
    Gallart-Palau, Xavier
    Serra, Aida
    AGEING RESEARCH REVIEWS, 2025, 105
  • [7] Transcriptional Effects of ApoE4: Relevance to Alzheimer's Disease
    Theendakara, Veena
    Peters-Libeu, Clare A.
    Bredesen, Dale E.
    Rao, Rammohan V.
    MOLECULAR NEUROBIOLOGY, 2018, 55 (06) : 5243 - 5254
  • [8] Transcriptional Effects of ApoE4: Relevance to Alzheimer’s Disease
    Veena Theendakara
    Clare A. Peters-Libeu
    Dale E. Bredesen
    Rammohan V. Rao
    Molecular Neurobiology, 2018, 55 : 5243 - 5254
  • [9] ApoE4: an emerging therapeutic target for Alzheimer’s disease
    Mirna Safieh
    Amos D. Korczyn
    Daniel M. Michaelson
    BMC Medicine, 17
  • [10] Development of ApoE4 targeted therapy of Alzheimer's disease
    Michaelson, D. M.
    Luz, I
    Liraz, O.
    Boehm, A.
    Smorodinsky, N., I
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S81 - S81